Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11872211 Treatments with nirogacestat

Patent 11872211 was granted and assigned to SpringWorks Therapeutics on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

SpringWorks Therapeutics

0

Current Assignee

SpringWorks Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shinta Cheng0

Todd Webster Shearer0

Allison Lim0

Rex Williams0

Kristin Patterson0

Date of Patent

January 16, 2024

0

Patent Application Number

183205470

Date Filed

May 19, 2023

0

Patent Citations

US Patent 10590087 Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

0

US Patent 7795447 Imidazole compounds for the treatment of neurodegenerative disorders

0

Patent Citations Received

US Patent 12011435 Treatments with nirogacestat

0

US Patent 11951096 Treatments with nirogacestat

0

US Patent 12011434 Treatments with nirogacestat

0

US Patent 11957662 Treatments with nirogacestat

0

Patent Primary Examiner

0

Patent abstract

The present disclosure relates to improved methods of treatment with nirogacestat.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11872211 Treatments with nirogacestat

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool